Wire Stories

Category Added in a WPeMatico Campaign

news_6

LianBio Announces Clearance to Initiate in China the Phase 2a Trial of Infigratinib in Patients with Locally Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma with FGFR2 Gene Amplification

SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--LianBio, a biotechnology company focused on bringing paradigm-shifting medicines to patients in China and other major...

news_6

Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors

NEW YORK--(BUSINESS WIRE)--Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of engineered viral immunotherapies, today announced enrollment of...

news_6

CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New Form of App-based Prescription Treatment – The First Digital Therapeutic to Be Covered by Japan’s Public Healthcare Insurance System

TOKYO--(BUSINESS WIRE)--#CureApp--CureApp, Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Kohta Satake) has announced that CureApp SC Nicotine Addiction Treatment App and CO...

news_6

Insights on the Global Data Center Market In Southeast Asia 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats – Technavio

LONDON--(BUSINESS WIRE)--#DataCenterMarketinSoutheastAsia--The data center market in Southeast Asia is expected to grow by USD 11.63 bn, decelerating at a CAGR...